![Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system - The Lancet Infectious Diseases Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/2bad233b-6d77-4165-b55f-8a2a249ec011/gr1.jpg)
Effectiveness of nirmatrelvir–ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system - The Lancet Infectious Diseases
![The Lancet Infectious Diseases | Vol 20, Issue 9, Pages 993-1100, e215-e249 (September 2020) | ScienceDirect.com by Elsevier The Lancet Infectious Diseases | Vol 20, Issue 9, Pages 993-1100, e215-e249 (September 2020) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S1473309920X00090-cov200h.gif)
The Lancet Infectious Diseases | Vol 20, Issue 9, Pages 993-1100, e215-e249 (September 2020) | ScienceDirect.com by Elsevier
![Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/d94350f3-51ae-4667-a156-b8ad998055ce/gr1.jpg)
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial - The Lancet Infectious Diseases
![The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later - The Lancet Infectious Diseases The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/0219316f-f621-4974-a326-38b55e17cb91/gr1_lrg.jpg)
The Lancet Infectious Diseases Commission on antimicrobial resistance: 6 years later - The Lancet Infectious Diseases
![The Lancet Infectious Diseases | Vol 21, Issue 1, Pages 1-148, e1-e16 (January 2021) | ScienceDirect.com by Elsevier The Lancet Infectious Diseases | Vol 21, Issue 1, Pages 1-148, e1-e16 (January 2021) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S1473309920X00132-cov200h.gif)